A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer

Clinical trial NCT00883116 · TERMINATED

Trial details

NCT number: NCT00883116
Sponsor: R-Pharm
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Endometrial Cancer

Start date: 2009-08-01
Primary completion: 2012-06-01
Enrollment: 551

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.